References
- Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994: 44(6 Suppl 4): S17–23
- MacGregor EA, Chia H, Vohrah RC, et al. Migraine and menstruation: a pilot study. Cephalalgia 1990; 10(6): 305–10
- Mortola JF, Girton L, Yen SS. Depressive episodes in premenstrual syndrome. Am J Obstet Gynecol 1989; 161: 1682–7
- Silberstein SD, Merriam GR. Sex hormones and headache. J Pain Symptom Manage 1993; 8(2): 98–114
- Silberstein SD. Serotonin (5-HT) and migraine. Headache 1994; 34(7): 408–17
- Awaki E, Takeshima T, Takahashi K. A neuroendocrinological study in female migraineurs: prolactin and thyroid stimulating hormone responses. Cephalalgia 1989; 9(3): 187–93
- Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995; 172(4 Pt 1): 1273–8
- Collins P, Shay J, Jiang C, et al. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994; 90(4): 1964–8
- Rosselli M, Imthurm B, Macas E, et al. Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun 1994; 202(3): 1543–52
- Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22(4): 355–65
- Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975; 25(3): 239–44
- Irwin J, Morse E, Riddick D. Dysmenorrhea induced by autologous transfusion. Obstet Gynecol 1981; 58(3): 286–90
- Nattero G, Allais G, De Lorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache 1989; 29(4): 233–8
- Carlson LA, Ekelund LG, Oro L. Clinical and metabolic effects of different doses of prostaglandin E1 in man. Prostaglandin and related factors. Acta Med Scand 1968; 183(5): 423–30
- Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 16(2): 157–68
- Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981; 9(4): 344–52
- Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988; 23(2): 193–6
- Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28(2): 183–7
- Engel JM, Rapoff MA. Biofeedback-assisted relaxation training for adult and pediatric headache disorders. Occup Ther J Res 1990; 10: 283–95
- Dennerstein L, Morse C, Burrows G, et al. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988; 2(2): 113–20
- Silberstein SD. The role of sex hormones in headache. Neurology 1992; 42(3 Suppl 2): 37–42
- Raskin NH. Headache. 2d ed. New York: Churchill Livingstone, 1988
- Szekely B, Merryman S, Croft H, et al. Prophylactic effects of naproxen sodium on perimenstrual headache: a double blind placebo controlled study. Cephalalgia 1989; 9(Suppl 10): 452–3
- Sanees G, Martignoni E, Fioroni L, et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990; 30(11): 705–9
- O'Dea JP, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology 1990; 40(9): 1470–1
- Andersch B, Hahn L, Wendestam C, et al. Treatment of premenstrual tension syndrome with bromocriptine. Acta Endocrinol (Suppl) (Copenh) 1978; 216: 165–74
- Lichten EM, Bennett RS, Whitty AJ, et al. Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991; 36(6): 419–24
- Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991; 72(2): 252A–252F
- Gallagher RM. Menstrual migraine and intermittent ergonovine therapy. Headache 1989; 29(6): 366–7
- D'Alessandro R, Gamberini G, Lozito A, et al. Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine. Cephalalgia 1983; 3(Suppl 1): 156–8
- Pilgrim AJ, Blakeborough P. The clinical efficacy of sumatriptan in the acute treatment of migraine. Rev Contemp Pharmacother 1994; 5: 295–309
- Solbach MP, Waymer RS. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993; 82(5): 769–72